KIMS Q1 FY27 results at a glance
KRISHNA INST OF MED SCI L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹1,180 cr |
|---|
| Revenue YoY | +35.3% |
|---|
| Operating profit | ₹123 cr |
|---|
| Operating margin | 10.4% |
|---|
| Net profit | ₹41.5 cr |
|---|
| Net profit YoY | -47.2% |
|---|
| Net profit QoQ | -2.4% |
|---|
| Net margin | 3.5% |
|---|
| Basic EPS | ₹1.04 |
|---|
| TTM revenue | ₹4,213 cr |
|---|
| TTM net profit | ₹204 cr |
|---|
| TTM net margin | 4.8% |
|---|
KIMS Q1 FY27 results: what the numbers say
KRISHNA INST OF MED SCI L (KIMS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹1,180 cr and a net profit of ₹41.5 cr, translating into earnings per share of ₹1.04.
Compared with the same quarter a year earlier, revenue grew strongly by +35.3% and net profit declined strongly by -47.2%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹123 cr, an operating margin of 10.4% versus 16.0% a year ago — a contraction of 5.6 percentage points.
KIMS quarter-wise results table
Revenue
₹1,180 cr
+35.3% YoY
Net profit
₹41.5 cr
-47.2% YoY
Operating profit
₹123 cr
-11.9% YoY
KRISHNA INST OF MED SCI L (KIMS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹1,180 cr | ₹123 cr | ₹41.5 cr | 10.4% | 3.5% | ₹1.04 | -47.2% | -2.4% |
| Q4 FY262026-03-31 | ₹1,075 cr | ₹122 cr | ₹42.5 cr | 11.3% | 4.0% | ₹1.06 | — | -20.4% |
| Q3 FY262025-12-31 | ₹998 cr | ₹120 cr | ₹53.4 cr | 12.0% | 5.4% | ₹1.33 | — | -20.2% |
| Q2 FY262025-09-30 | ₹961 cr | ₹138 cr | ₹66.9 cr | 14.4% | 7.0% | ₹1.67 | — | -14.9% |
| Q1 FY262025-06-30 | ₹872 cr | ₹139 cr | ₹78.6 cr | 16.0% | 9.0% | ₹1.96 | — | — |
| TTM (last 4 quarters) | ₹4,213 cr | ₹502 cr | ₹204 cr | 11.9% | 4.8% | ₹5.10 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
KIMS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
KRISHNA INST OF MED SCI L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹1,180 cr | ₹1,075 cr | ₹998 cr | ₹961 cr | ₹872 cr |
|---|
| Total expenses | ₹1,057 cr | ₹953 cr | ₹878 cr | ₹823 cr | ₹732 cr |
|---|
| Gross profit | ₹722 cr | ₹662 cr | ₹801 cr | ₹766 cr | ₹537 cr |
|---|
| Operating profit (EBIT) | ₹123 cr | ₹122 cr | ₹120 cr | ₹138 cr | ₹139 cr |
|---|
| Operating margin | 10.4% | 11.3% | 12.0% | 14.4% | 16.0% |
|---|
| Interest cost | ₹83.4 cr | ₹68.1 cr | ₹56.8 cr | ₹45 cr | ₹32.6 cr |
|---|
| Profit before tax | ₹56.6 cr | ₹54.8 cr | ₹68.6 cr | ₹96.8 cr | ₹114 cr |
|---|
| Tax expense | ₹19.2 cr | ₹21.7 cr | ₹16.7 cr | ₹24.8 cr | ₹28.7 cr |
|---|
| Effective tax rate | 33.9% | 39.6% | 24.3% | 25.6% | 25.2% |
|---|
| Net profit (PAT) | ₹41.5 cr | ₹42.5 cr | ₹53.4 cr | ₹66.9 cr | ₹78.6 cr |
|---|
| Net profit margin | 3.5% | 4.0% | 5.4% | 7.0% | 9.0% |
|---|
| Basic EPS | ₹1.04 | ₹1.06 | ₹1.33 | ₹1.67 | ₹1.96 |
|---|
| Diluted EPS | ₹1.04 | ₹1.06 | ₹1.33 | ₹1.67 | ₹1.96 |
|---|
KIMS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +35.3% | — | — | — | — |
|---|
| Revenue QoQ | +9.8% | +7.7% | +3.9% | +10.2% | — |
|---|
| Operating profit YoY | -11.9% | — | — | — | — |
|---|
| Operating profit QoQ | +0.9% | +1.1% | -12.8% | -0.9% | — |
|---|
| Net profit YoY | -47.2% | — | — | — | — |
|---|
| Net profit QoQ | -2.4% | -20.4% | -20.2% | -14.9% | — |
|---|
| EPS YoY | -46.9% | — | — | — | — |
|---|
| EPS QoQ | -1.9% | -20.3% | -20.4% | -14.8% | — |
|---|
KIMS annual results history
Full-year performance for KRISHNA INST OF MED SCI L, useful for reading each quarter in context.
KRISHNA INST OF MED SCI L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹3,872 cr | ₹3,004 cr | ₹2,474 cr | ₹2,168 cr |
|---|
| Total expenses | ₹3,337 cr | ₹2,388 cr | ₹1,973 cr | ₹1,686 cr |
|---|
| Gross profit | ₹2,429 cr | ₹1,912 cr | ₹1,521 cr | ₹1,341 cr |
|---|
| Operating profit (EBIT) | ₹535 cr | ₹616 cr | ₹501 cr | ₹482 cr |
|---|
| Operating margin | 13.8% | 20.5% | 20.3% | 22.2% |
|---|
| Interest cost | ₹197 cr | ₹88.7 cr | ₹46.4 cr | ₹29.32 cr |
|---|
| Profit before tax | ₹334 cr | ₹558 cr | ₹460 cr | ₹485 cr |
|---|
| Tax expense | ₹91.9 cr | ₹143 cr | ₹124 cr | ₹119 cr |
|---|
| Effective tax rate | 27.5% | 25.7% | 26.9% | 24.6% |
|---|
| Net profit (PAT) | ₹241 cr | ₹385 cr | ₹310 cr | ₹336 cr |
|---|
| Net profit margin | 6.2% | 12.8% | 12.5% | 15.5% |
|---|
| Basic EPS | ₹6.03 | ₹9.61 | ₹7.75 | ₹8.41 |
|---|
| Diluted EPS | ₹6.03 | ₹9.61 | ₹7.75 | ₹8.41 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹1,180 cr against ₹872 cr in Q1 FY26, and ₹1,075 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +9.8%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹1,057 cr, or 89.6% of revenue, with operating profit declined -11.9% year on year.
Margins, tax and profitability
Net profit of ₹41.5 cr works out to a net margin of 3.5% compared with 9.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, KRISHNA INST OF MED SCI L reported profit before tax of ₹56.6 cr, a tax charge of ₹19.2 cr (effective rate 33.9%), interest cost of ₹83.4 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹42.5 cr in Q4 FY26 to ₹41.5 cr in Q1 FY27, a change of -2.4%.
Trailing twelve months and annual context
Across the trailing four quarters KRISHNA INST OF MED SCI L has generated revenue of ₹4,213 cr and net profit of ₹204 cr, a trailing net margin of 4.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹3,872 cr with net profit of ₹241 cr and EPS of ₹6.03, versus the prior year where revenue grew +28.9% and profit declined -37.2%.
What to watch in the next KIMS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
KRISHNA INST OF MED SCI L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
KIMS results coverage
No results report published for KIMS yet — our desk covers each quarter within minutes of the filing.
More on KIMS
KIMS quarterly results FAQs
What were KRISHNA INST OF MED SCI L (KIMS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), KRISHNA INST OF MED SCI L reported revenue of ₹1,180 cr and net profit of ₹41.5 cr, a change of -47.2% year on year on +35.3% revenue growth. EPS stood at ₹1.04.
What is KIMS profit margin in Q1 FY27?
KRISHNA INST OF MED SCI L posted a net profit margin of 3.5% and an operating margin of 10.4% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹4,213 cr and net profit ₹204 cr.
Did KIMS results beat the previous quarter?
KRISHNA INST OF MED SCI L net profit changed -2.4% quarter on quarter, from ₹42.5 cr in Q4 FY26 to ₹41.5 cr in Q1 FY27.
When are KRISHNA INST OF MED SCI L (KIMS) quarterly results?
KRISHNA INST OF MED SCI L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see KIMS latest quarterly results?
Results coverage for KIMS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the KIMS stock page.
What is KRISHNA INST OF MED SCI L annual revenue and profit?
For FY26, KRISHNA INST OF MED SCI L reported full-year revenue of ₹3,872 cr and net profit of ₹241 cr, with EPS of ₹6.03.
How many quarterly results has KIMS declared recently?
Past results dates for KIMS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
